GBA's "2021 Stock Phantasma"

Discussion in 'Stocks' started by stonedinvestor, Jan 1, 2021.


  1. The more they talk about Booster shots the less attractive these fringe vax makers are. Since the mix and match of vaccines has not been blessed. There was some talk of this option in the past.

    Focus on the nose. Someone is going to nail that... and it damn well could be Atossa! But probably six bios are working on a spray & imagine that! A quick sniff and Van's out the door... like an allergy spray. The big problem is these non symptomatic carriers and what the nose spray does is kill the virus where it hides in those people before they wipe their nose and touch the hand railing at the airport and then you touch the railing and touch your face.
     
    #8001     Aug 20, 2021
  2. Van you've heard of
    RILY-B. Riley Financial<-- They've been around for a long time... You know when the market tanked year or so ago I came up with an amazing trade on LAZard (similar co) based off their dividend. It really worked out great. Stk doubled / dividend shrank but was constant and large total return off the charts. See if B Riley has a Div?
    $60.36

    -2.88(-4.55%)
     
    #8002     Aug 20, 2021
  3. MAILBAG-

    Dear GBA I bought VERB at $1.76 at 2 pm. and sold at $1.90 at 3:55.
    Thank You For What You Do.- Johnny V Sarasota Fla.
     
    #8003     Aug 20, 2021
  4. vanzandt

    vanzandt

    An allergy spray was not the first thing that came to mind.

    Hey your weight-loss drug.... its not new. Looks like its been around awhile.
    Is it generic?

    Semaglutide
    https://en.wikipedia.org/wiki/Semaglutide

    Wegovy (semaglutide), Ozempic (semaglutide), and Rybelsus (semaglutide) all contain semaglutide, but they are used for different conditions. Wegovy (semaglutide) is used for weight loss, whereas Ozempic and Rybelsus are used for type 2 diabetes. Like Wegovy (semaglutide), Ozempic is also an injection, but the dose is much lower for diabetes. Rybelsus is a tablet that is taken by mouth. Like other GLP-1 agonists, semaglutide can also lower blood sugar levels by affecting the release of insulin and glucagon, two natural hormones in your body that regulate blood sugar levels.
     
    #8004     Aug 20, 2021
  5. vanzandt

    vanzandt

    Yikes!
    It does.
    10.6%
     
    #8005     Aug 20, 2021
  6. THE BOTTOM SNIFFER PRESENTS-
    THE BS REPORT**
    ATOS-Chart Events

    [​IMG]
    Bullishpattern detected<-- Woa!
    [​IMG]
    Engulfing Line (Bullish)<- What>?

    Back to March 12th levels with ATOS!

    In a layer of support!

    March 11th $3.22 high....May 17th $3.23---> Aug 4th $3.15... SNIFF SNIFFF....
     
    #8006     Aug 20, 2021
  7. I think people are paid big bucks to come up with these drug names.

    Who came up with- Semaglutide. I mean really....
     
    #8007     Aug 20, 2021

  8. Yea so play this right and your off to the rich people's island. Total return is great in this kind of stagflation environment.
     
    #8008     Aug 20, 2021
  9. I cannot verify this (yet).... From a Yahoo message board!

    yesterday
    Posted this 2 days ago but for those that missed it:
    Scheduled a special stockholder meeting for September 7, 2021 for the purpose of approving an increase in authorized shares of common stock. If the proposal is approved by the stockholders, Atossa does not intend to issue any of the newly authorized shares of common stock for the purpose of raising capital in the nine months following approval of the proposal at a price less than $10 per share.

    Yes, you are reading this right: NO LESS THAN $ 10 per SHARE.
     
    #8009     Aug 20, 2021
    vanzandt likes this.
  10. "If the proposal is approved by the stockholders, Atossa does not intend to issue any of the newly authorized shares of common stock for the purpose of raising capital in the nine months following approval of the proposal at a price less than $10 per share. The newly authorized shares of common stock are intended to be used at any time to complete and/or support acquisitions, collaborations, partnerships and licensing transactions."
     
    #8010     Aug 20, 2021